Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)
1 other identifier
observational
236
4 countries
5
Brief Summary
The purpose of the protocol is to develop final draft PRO instruments of physical activity in daily life to be used and evaluated in the further validation studies measuring physical activity in chronic obstructive pulmonary disease (COPD) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2011
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 4, 2011
CompletedFirst Posted
Study publicly available on registry
July 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedApril 27, 2018
July 1, 2015
5 months
July 4, 2011
April 26, 2018
Conditions
Keywords
Study Arms (2)
Arm 1 - Daily+Clinical
Order of assessment: Daily PRO + Clinical visit PRO
Arm 2 - Clinical+Daily
Order of assessment: Clinical visit PRO + Daily PRO
Eligibility Criteria
Stable COPD patients from Outpatients clinics and Primary care clinic Exacerbated COPD patients from Inpatients
You may qualify if:
- Diagnosis of COPD (Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria: post bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC)\<70%) confirmed with spirometry in stable clinical conditions. For patients recruited during an exacerbation, the diagnosis of COPD should be confirmed in stable conditions.
- Current or ex-smokers with a smoking history equivalent to at least 10 pack years.
- Able to read and write and to use electronic devices and physical activity monitor.
You may not qualify if:
- Orthopaedic, neurological or other complaints that significantly impair normal biomechanical movement patterns, as judged by the investigator.
- Respiratory diseases other than COPD (e.g. asthma).
- Cognitive impairment, as judged by the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Barcelona Institute for Global Healthlead
- KU Leuvencollaborator
- University of Edinburghcollaborator
- Royal Brompton & Harefield NHS Foundation Trustcollaborator
- University Medical Center Groningencollaborator
- University of Athenscollaborator
Study Sites (5)
University Hospital Gasthuisberg, Katholieke Universiteit Leuven
Leuven, 3000, Belgium
Thorax Research Foundation
Athens, Greece
University Medical Center
Groningen, Netherlands
Royal Brompton Hospital, Imperial College
London, England, SW3 6NP, United Kingdom
ELEGI/Colt laboratory UoE/MRC Centre for Inflammation Research The Queen's Medical Research Institute, University of Edinburgh
Edinburgh, Scotland, EH16 4TJ, United Kingdom
Related Publications (2)
Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich RA, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer WI, van der Molen T, Kulich K, Serra I, Basagana X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J; PROactive consortium. The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease. Eur Respir J. 2015 Oct;46(4):988-1000. doi: 10.1183/09031936.00183014. Epub 2015 May 28.
PMID: 26022965RESULTDemeyer H, Gimeno-Santos E, Rabinovich RA, Hornikx M, Louvaris Z, de Boer WI, Karlsson N, de Jong C, Van der Molen T, Vogiatzis I, Janssens W, Garcia-Aymerich J, Troosters T, Polkey MI; PROactive consortium. Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used. PLoS One. 2016 Mar 14;11(3):e0151255. doi: 10.1371/journal.pone.0151255. eCollection 2016.
PMID: 26974332DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Judith Garcia-Aymerich, MD, PhD
Barcelona Institute for Global Health
- STUDY CHAIR
Niklas Karlsson
AstraZeneca
- PRINCIPAL INVESTIGATOR
Thierry Troosters
KUL Leuven
- PRINCIPAL INVESTIGATOR
Thys van der Molen
University Medical Center Groningen
- PRINCIPAL INVESTIGATOR
Nick Hopkinson, MD
Imperial College London
- PRINCIPAL INVESTIGATOR
Roberto Rabinovich, MD, PhD
University of Edinburgh
- PRINCIPAL INVESTIGATOR
Ioannis Vogiatzis, PhD
Thorax Research Foundation Athens
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2011
First Posted
July 6, 2011
Study Start
July 1, 2011
Primary Completion
December 1, 2011
Study Completion
December 1, 2012
Last Updated
April 27, 2018
Record last verified: 2015-07